Egypt's health ministry said the country will receive more shipments of Sinopharm's COVID-19 vaccine through the United Arab Emirates (UAE) later this week, reported Egypt Independent.
Ministry spokesman Khaled Megahid said a meeting between Egyptian and Emirati counterparts discussed the UAE's desire for Egypt to become a center for vaccine production in Africa and the Middle East.
Megahid explained that the health minister discussed the possibility of transferring Sinopharm's technological expertise in drug production to Egypt.
He added that vaccine factories in the Holding Company for Biological Products and Vaccines (VACSERA) are qualified to manufacture vaccines inside Egypt, and that there is a complete review process for production lines regarding vaccines.
The Emirates company G42 Healthcare, a subsidiary of the Abu Dhabi-based technology company Group 42, is the agent of Sinopharm in the Middle East and North Africa.
Earlier this month, Egypt received its first shipment of Sinopharm's coronavirus vaccine, which is said to be 86% effective. The vaccine will be free for Egyptians, with the first doses being reserved for healthcare workers and at-risk populations.
To read more NewsPoints articles, click here.